Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/9470
Title
And fibrinolysis became pharmacoinvasive
Author(s)
Date issued
2020-02-14
Citation
Eur Heart J. 2020; 51(7):855-7
Language
Inglés
Abstract
This editorial refers to ‘16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction’†, by P.G. Thrane et al.
Online version
DOI
Collections
